May is Skin Cancer Awareness Month

Since skin cancer awareness is in full effect for the month of May, it's important to recognize what skin cancer truly looks like. Take a look at the slide show for more images.

Recent Content

Clinicians soon may have a new tool for staging prostate cancer and predicting survival. Investigators at Indiana University School of Medicine are reporting in the May 14, 2015 online edition of the journal Cancer Cell, that the protein transforming growth factor beta (TGF-beta) is involved in metastatic prostate cancer.

An elevated PSA score may mean there are cancer cells, but not always. But now, a less invasive test can help more precisely determine if that biopsy is necessary.

A new study by an international team led by researchers at the University of California, San Francisco (UCSF), has shed light on the mechanism of action for the anticancer effects of the Haemophilus influenzae Type b (Hib) vaccine, specifically against acute lymphoblastic leukemia (ALL).

MEDI4736 appears to have an acceptable safety profile and durable clinical activity, according to a new dose-escalation study.

Cuba is well known in the US for high quality cigars and rum, but less widely appreciated is the innovative research carried out in Cuba’s Center for Molecular Immunology. That could change if clinical studies of the cancer vaccine CIMAvax go well.

Venetoclax, an inhibitor of the B-cell lymphoma-2 (BCL-2) protein, is getting the green light from US Food and Drug Administration (FDA).

Initiation and progression of the rare and often fatal brain cancer, choroid plexus carcinoma (CPC), depends on the presence of genes transcription initiation factor TFIID subunit 12 (TAF12) and nuclear transcription factor Y (NFYC), both transcription factors that regulate the epigenome, and DNA repair and recombination protein RAD54-like (RAD54L), a component in DNA homologous repair.

By clicking Accept, you agree to become a member of the UBM Medica Community.